139 related articles for article (PubMed ID: 3091604)
1. Purification and characterization of a novel inhibitor of urokinase from human urine. Quantitation and preliminary characterization in plasma.
Stump DC; Thienpont M; Collen D
J Biol Chem; 1986 Sep; 261(27):12759-66. PubMed ID: 3091604
[TBL] [Abstract][Full Text] [Related]
2. Urokinase-related proteins in human urine. Isolation and characterization of single-chain urokinase (pro-urokinase) and urokinase-inhibitor complex.
Stump DC; Thienpont M; Collen D
J Biol Chem; 1986 Jan; 261(3):1267-73. PubMed ID: 3080422
[TBL] [Abstract][Full Text] [Related]
3. Isolation and characterization of alpha2-plasmin inhibitor from human plasma. A novel proteinase inhibitor which inhibits activator-induced clot lysis.
Moroi M; Aoki N
J Biol Chem; 1976 Oct; 251(19):5956-65. PubMed ID: 134998
[TBL] [Abstract][Full Text] [Related]
4. Purification of human fibroblast urokinase proenzyme and analysis of its regulation by proteases and protease nexin.
Eaton DL; Scott RW; Baker JB
J Biol Chem; 1984 May; 259(10):6241-7. PubMed ID: 6373753
[TBL] [Abstract][Full Text] [Related]
5. Detection and partial characterization of a specific plasminogen activator inhibitor in human chondrocyte cultures.
Yamada H; Stephens RW; Nakagawa T; McNicol D
J Biochem; 1988 Dec; 104(6):960-7. PubMed ID: 3149640
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of urokinase by complex formation with human antithrombin III in absence and presence of heparin.
Clemmensen I
Thromb Haemost; 1978 Jun; 39(3):616-23. PubMed ID: 705690
[TBL] [Abstract][Full Text] [Related]
7. An inhibitor of plasminogen activation from human placenta. Purification and characterization.
Wun TC; Reich E
J Biol Chem; 1987 Mar; 262(8):3646-53. PubMed ID: 3102492
[TBL] [Abstract][Full Text] [Related]
8. Purification and characterization of single-chain urokinase-type plasminogen activator from human cell cultures.
Stump DC; Lijnen HR; Collen D
J Biol Chem; 1986 Jan; 261(3):1274-8. PubMed ID: 3080423
[TBL] [Abstract][Full Text] [Related]
9. Different molecular forms of plasminogen and plasmin produced by urokinase in human plasma and their relation to protease inhibitors and lysis of fibrinogen and fibrin.
Müllertz S
Biochem J; 1974 Nov; 143(2):273-83. PubMed ID: 4282470
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a recombinant fusion protein of the finger domain of tissue-type plasminogen activator with a truncated single chain urokinase-type plasminogen activator.
Gheysen D; Lijnen HR; Piérard L; de Foresta F; Demarsin E; Jacobs P; De Wilde M; Bollen A; Collen D
J Biol Chem; 1987 Aug; 262(24):11779-84. PubMed ID: 3114253
[TBL] [Abstract][Full Text] [Related]
11. Complex formation between urokinase and plasma protein C inhibitor in vitro and in vivo.
Geiger M; Huber K; Wojta J; Stingl L; Espana F; Griffin JH; Binder BR
Blood; 1989 Aug; 74(2):722-8. PubMed ID: 2752144
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a chimeric plasminogen activator consisting of amino acids 1 to 274 of tissue-type plasminogen activator and amino acids 138 to 411 of single-chain urokinase-type plasminogen activator.
Lijnen HR; Nelles L; Van Hoef B; Demarsin E; Collen D
J Biol Chem; 1988 Dec; 263(35):19083-91. PubMed ID: 3143723
[TBL] [Abstract][Full Text] [Related]
13. Concomitant secretion of prourokinase and of a plasminogen activator-specific inhibitor by cultured human monocytes-macrophages.
Vassalli JD; Dayer JM; Wohlwend A; Belin D
J Exp Med; 1984 Jun; 159(6):1653-68. PubMed ID: 6374011
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of urokinase by complex formation with human alpha1-antitrypsin.
Clemmensen I; Christensen F
Biochim Biophys Acta; 1976 Apr; 429(2):591-9. PubMed ID: 1083251
[TBL] [Abstract][Full Text] [Related]
15. Inhibitor of plasminogen activator in human arterial wall. II. Biochemical characterization.
Okamura T; Nanno S; Sueishi K; Tanaka K
Acta Pathol Jpn; 1984 Jul; 34(4):749-57. PubMed ID: 6237547
[TBL] [Abstract][Full Text] [Related]
16. Purification and characterization of a plasminogen activator inhibitor 1 binding protein from human plasma. Identification as a multimeric form of S protein (vitronectin).
Declerck PJ; De Mol M; Alessi MC; Baudner S; Pâques EP; Preissner KT; Müller-Berghaus G; Collen D
J Biol Chem; 1988 Oct; 263(30):15454-61. PubMed ID: 2459123
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of urokinase by protein C-inhibitor (PCI). Evidence for identity of PCI and plasminogen activator inhibitor 3.
Stief TW; Radtke KP; Heimburger N
Biol Chem Hoppe Seyler; 1987 Oct; 368(10):1427-33. PubMed ID: 3501295
[TBL] [Abstract][Full Text] [Related]
18. Purification and characterization of a plasminogen activator secreted by a pig kidney cell line.
Sudol M; Reich E
Biochem J; 1984 May; 219(3):971-8. PubMed ID: 6430276
[TBL] [Abstract][Full Text] [Related]
19. Competition of activated protein C and urokinase for a heparin-dependent inhibitor.
Geiger M; Heeb MJ; Binder BR; Griffin JH
FASEB J; 1988 Apr; 2(7):2263-7. PubMed ID: 3350241
[TBL] [Abstract][Full Text] [Related]
20. Purification and characterization of tissue-type plasminogen activator in maxillary mucosa with chronic inflammation.
Hamaguchi Y; Ohi M; Sakakura Y; Miyoshi Y
Thromb Haemost; 1985 Aug; 54(2):485-9. PubMed ID: 3936218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]